Skip to main content
EU approves troponin assay from Singulex
6/2/2017

European regulators have given Singulex the CE mark for its Sgx Clarity cTnl assay for use in quantitative measurement of troponin. The assay, which is available on the company's Sgx Clarity fully automated in vitro diagnostic platform, is indicated to be used with clinical evaluation for ruling out cardiac ischemia in patients with suspected coronary artery disease.

Full Story: